Opendata, web and dolomites

PODIUM SIGNED

PODIUM™ - A home device and cloud-based software and algorithm for diabetic foot ulcer monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PODIUM project word cloud

Explore the words cloud of the PODIUM project. It provides you a very rough idea of what is the project "PODIUM" about.

instead    diagnostic    adults    small    global    dfus    premature    5bn    75    healthcare    us    10x    cholesteric       trade    imaging    thermetrix    cloud    convenience    plus    diabetes    9m    conventional    rate    60m    considerable    290    2015    24    crystalline    physicians    validate    23    solutions    risk    5m    2025    experiment    subscription    pressure    complications    rapid    450    dramatically    generating    complication    threatening    europeans    solution    sales       85    8m    limb    8bn    1m    lifetime    25    unsuccessful    consequence    diabetics    grow    reduce    market    model    uk    sufferers    foot    sensitivity    improvement    suffering    ulcer    diabetic    ulcers    qol    extremely    dfu    cameras    12    amputations    substantial    mainly    reported    mortality    diagnosis    savings    sensitive    competitive    liquid    suffer    roi    monitoring    456    percentage    temperature    effectiveness    detection    revealed    2024    lower    business    esters    life    quality    efficacy    cagr    infrared    amputation    introduction    thermographs    facilitated    prevented    treatment    podium    amounting    deaths       decreasing    9bn    serious    caused   

Project "PODIUM" data sheet

The following table provides information about the project.

Coordinator
THERMETRIX LTD. 

Organization address
address: TY MENTER NAVIGATION PARK SUITE 12
city: ABERCYNON
postcode: CF45 4SN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://podium.care/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THERMETRIX LTD. UK (ABERCYNON) coordinator 50˙000.00

Map

 Project objective

'There are 60m adults suffering from diabetes in Europe and 3.8m in UK (5m by 2025). Diabetes has a high mortality rate caused mainly by complications (75,000 deaths p.a., of which 24,000 are premature). One life-threatening complication of diabetes is a diabetic foot ulcer (DFU). Studies revealed a 12% to 25% lifetime risk of developing DFU for diabetics, meaning over 9m Europeans (c.456,000 to 1m in UK) might suffer from DFU in their lifetime. A serious consequence of DFU is lower limb amputation; 85% of the amputations in diabetes sufferers are reported after unsuccessful DFU treatment amounting to 290,000–450,000 amputations/year in Europe, at a cost of €2–2.5bn/year.

The PODIUM™ technology is a novel, extremely reliable and highly sensitive solution for the cost-effective diagnosis and monitoring of DFUs through rapid temperature imaging and reliable analysis of thermographs. PODIUM™ will result in increased numbers of prevented DFUs through 10X higher sensitivity than any competitive solutions. A timely response from physicians, facilitated by PODIUM™ could reduce DFU-related amputations and healthcare costs. Thermetrix’s technology will provide a considerable Quality of Life (QoL) improvement for users and enable substantial savings in healthcare even if only a very small percentage would adopt PODIUM™. The global DFU and pressure ulcers market is expected to grow from US$2.8bn in 2015 to US$4.9bn by 2024 (CAGR 6.6%).

The objectives of this project are (1) experiment with the introduction of liquid crystalline cholesteric esters instead of infrared-cameras as detection method (dramatically decreasing the cost of the method); (2) validate the higher efficacy, diagnostic value, convenience and cost-effectiveness of PODIUM™ over conventional approaches; and (3) validate the business model based on 'unit costs plus cloud subscription' with the aim of generating a ROI of 23:1 based only on European sales only.

'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PODIUM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PODIUM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More  

STURSKIN (2018)

Innovative products by using tanned sturgeon skin

Read More